IASLC, 2023. — 219 p. — (International Association for the Study of Lung Cancer). — ISBN 979-8-9878292-0-2.
The IASLC’s latest Atlas provides a comprehensive overview of all current and emerging molecular targets, specimen acquisition, available assays, and reporting and interpretation of molecular testing results from both a diagnostic and clinical perspective.
Introduction
Clinical Relevance of Biomarker Testing in Lung Cancer
Specimen Acquisition and Pre-Analytical Considerations
Liquid Biopsy: Specimen Acquisition, Testing Strategies, and Clinical Roles
Technologies for Detection of Biomarkers
A Global Perspective on Molecular Testing Guidelines and Practices
EGFR
ALK
ROS1
BRAF
NTRK
RET
MET
KRAS
HER2
NRG1
New Targets and Technologies
Molecular Testing Results and the Role of Multidisciplinary Molecular Tumor Boards
Molecular Biomarker Testing Algorithms
Summary and Future Perspectives